1,026
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Thyroid dysfunctions induced by tyrosine kinase inhibitors

, MD, , MSc, , MD, , MSc, , MSc, & show all
Pages 723-733 | Published online: 12 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Ilaria Ruffilli, Armando Patrizio, Gabriele Materazzi & Alessandro Antonelli. (2019) Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes. Cancer Management and Research 11, pages 7893-7907.
Read now
Poupak Fallahi, Silvia Martina Ferrari, Ilaria Ruffilli, Francesca Ragusa, Marco Biricotti, Gabriele Materazzi, Paolo Miccoli & Alessandro Antonelli. (2017) Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update. Expert Opinion on Drug Delivery 14:5, pages 647-655.
Read now
Jolanta Krajewska, Ewa Paliczka-Cieslik & Barbara Jarzab. (2017) Managing tyrosine kinase inhibitors side effects in thyroid cancer. Expert Review of Endocrinology & Metabolism 12:2, pages 117-127.
Read now
Poupak Fallahi, Silvia Martina Ferrari, Enke Baldini, Marco Biricotti, Salvatore Ulisse, Gabriele Materazzi, Paolo Miccoli & Alessandro Antonelli. (2016) The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer. Expert Review of Anticancer Therapy 16:11, pages 1109-1118.
Read now
Poupak Fallahi, Flavia Di Bari, Silvia Martina Ferrari, Roberto Spisni, Gabriele Materazzi, Paolo Miccoli, Salvatore Benvenga & Alessandro Antonelli. (2015) Selective use of vandetanib in the treatment of thyroid cancer. Drug Design, Development and Therapy 9, pages 3459-3470.
Read now
Honey V Reddi, Anirudh Kumar & Roger Kulstad. (2015) Anaplastic thyroid cancer – an overview of genetic variations and treatment modalities. Advances in Genomics and Genetics 5, pages 43-52.
Read now

Articles from other publishers (12)

Liu Yang, Ping-hui Tu, Cao-xu Zhang, Rong-rong Xie, Mei Dong, Yu Jing, Xia Chen, Gang Wei & Huai-dong Song. (2023) Influence of two anti-tumor drugs, pazopanib, and axitinib, on the development and thyroid-axis of zebrafish (Danio rerio) embryos/larvae. Frontiers in Endocrinology 14.
Crossref
Philippe Caron, Solange Grunenwald, Luca Persani, Françoise Borson-Chazot, Remy Leroy & Leonidas Duntas. (2021) Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults. Reviews in Endocrine and Metabolic Disorders 23:3, pages 463-483.
Crossref
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, Sabrina Rosaria Paparo, Valeria Mazzi, Enke Baldini, Salvatore Benvenga, Alessandro Antonelli & Poupak Fallahi. (2021) Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism. Frontiers in Pharmacology 12.
Crossref
Alessandro Antonelli, Leonard Wartofsky & Paolo Miccoli. (2021) Editorial: Levothyroxine Therapy in Patients With Hypothyroidism. Frontiers in Endocrinology 12.
Crossref
Alessandro Antonelli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Gabriella Cavallini, Salvatore Benvenga, Silvia Martina Ferrari & Poupak Fallahi. (2021) The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine. Frontiers in Endocrinology 12.
Crossref
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo & Alessandro Antonelli. (2021) L-T4 Therapy in Enteric Malabsorptive Disorders. Frontiers in Endocrinology 12.
Crossref
Masako Shomura, Haruka Okabe, Emi Sato, Kota Fukai, Koichi Shiraishi, Shunji Hirose, Kota Tsuruya, Yoshitaka Arase, Kazuya Anzai & Tatehiro Kagawa. (2020) Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy. Cancers 12:11, pages 3078.
Crossref
M. Popović, A. Matana, V. Torlak, T. Boutin, D. Brdar, I. Gunjača, D. Kaličanin, I. Kolčić, V. Boraska Perica, A. Punda, O. Polašek, M. Barbalić, C. Hayward & T. Zemunik. (2019) Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone. Journal of Endocrinological Investigation 42:10, pages 1171-1180.
Crossref
Sean T. Toenjes, Valeria Garcia, Sean M. Maddox, Gregory A. Dawson, Maria A. Ortiz, F. Javier Piedrafita & Jeffrey L. Gustafson. (2019) Leveraging Atropisomerism to Obtain a Selective Inhibitor of RET Kinase with Secondary Activities toward EGFR Mutants. ACS Chemical Biology 14:9, pages 1930-1939.
Crossref
Ya B Balzhanova, E N Parovichnikova, A N Sokolov, V V Ryzhko, M A Samtsova & E O Gribanova. (2019) Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation. Terapevticheskii arkhiv 91:8, pages 93-97.
Crossref
Omar Abdel-Rahman & Mona Fouad. (2015) Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature. Critical Reviews in Oncology/Hematology 94:2, pages 238-250.
Crossref
Iordanis Mourouzis, Alexandros Tzovaras, Basil Armonis, Alexandros Ardavanis, Maria Skondra, John Misitzis, Demetrios Pectasides & Constantinos Pantos. (2015) Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?. International Journal of Endocrinology 2015, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.